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Background: Little is known about psychologi-
cal risk factors in cerebrovascular disease. We
examined the association between psycholog-
ical distress and risk of death due to cere-
brovascular disease.
Methods: We obtained data from 68 652
adult participants of the Health Survey for
England (mean age 54.9 [standard deviation
13.9] yr, 45.0% male sex) with no known his-
tory of cardiovascular diseases at baseline. We
used the 12-item General Health Question-
naire (GHQ-12) to assess the presence of psy-
chological distress. We followed participants
for eight years for cause-specific death using
linkage to national registers.
Results: There were 2367 deaths due to car-
diovascular disease during follow-up. Relative
to participants with no symptoms of psycho-
logical distress (GHQ-12 score 0) at baseline,
people with psychological disress (GHQ-12
score ≥ 4, 14.7% of participants) had an
increased risk of death from cerebrovascular
disease (adjusted hazard ratio [HR] 1.66, 95%
confidence interval [CI] 1.32–2.08) and
ischemic heart disease (adjusted HR 1.59,
95% CI 1.34–1.88). There was also evidence of
a dose–response effect with increasing GHQ-
12 score (p for trend < 0.001 in all analyses).
Associations were only marginally attenuated
after we adjusted for possible confounders,
including socioeconomic status, smoking and
use of antihypertensive medications.
Interpretation: Psychological distress was asso-
ciated with increased risk of death due to
cerebrovascular disease in a large population-
representative cohort. These data suggest
that the cardiovascular effects of psychologi-
cal distress are not limited to coronary artery
disease.
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Psychological constructs are becomingincreasingly recognized as risk factors andtriggers for cardiovascular events.1 To date,
most cardiovascular research has focused on
coronary artery disease rather than cerebrovascu-
lar disease. Several studies have examined the
association between symptoms of depression and
risk of stroke,2–11 although the results have been
inconsistent, and effect sizes are generally mod-
est.12 For example, some evidence from epidemi-
ological studies has shown a relation between
depression and incident stroke.2–7 However, a
recent study showed an association between
depression and coronary artery disease but not
cerebrovascular disease.11 This finding is consis-
tent with other analyses that have also found null
associations for stroke outcomes.8–10 Other investi-
gators have suggested that psychological distress
is a more robust predictor of stroke than are
symptoms of depression.13
In addition to a paucity of evidence linking
psychological distress with risk of stroke, extant
evidence is hampered by a series of methodolog-
ical problems. These limitations include small
sample sizes (including rarity of outcome), a
limited range of confounding data, an unknown
influence of existing comorbidity on psychologi-
cal distress (reverse causality) and few data from
women. We addressed these shortcomings by
examining the association between psychologi-
cal distress and risk of death due to cerebrovas-
cular disease in a large, well-characterized
cohort of men and women representative of the
general population.
Methods
Participants and study design
We drew our participants from those recruited for
the Health Survey for England, a representative,
general population–based study sampling people
living in households.14 Participants are selected
using a multistage stratified probability design to
give a representative sample of the target popula-
tion in each survey year. Stratification is based on
geography rather than individual characteristics,
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with postal codes selected at the first stage and
household addresses selected at the second stage.
The overall rate of response ranged between 60%
and 90% in different survey years.
We used a prospective cohort design. We
pooled participants from 10 different survey years
(1994–2004; Appendix 1, available at www
.cmaj.ca /lookup /suppl /doi :10 .1503 /cmaj .111719 /-/
DC1). We linked study participants to mortality
data from the National Health Service and fol-
lowed them until Feb. 28, 2008. Study partici-
pants gave their full informed consent. The
study was approved by the London Multicentre
Research Ethics Committee.
Primary outcome measure
Our primary outcome measure was death due to
cerebrovascular disease. Our primary exposure
variable of interest was psychological distress.
During a household visit, interviewers col-
lected information using computer-assisted per-
sonal interviewing modules. Psychological dis-
tress was measured using the 12-item version of
the General Health Questionnaire (GHQ-12), a
widely used measure of psychological distress in
population studies. 15 The GHQ-12 is a unidimen-
sional scale16 consisting of items relating to anxi-
ety, depression, social dysfunction and loss of
confidence. Answers are interpreted according to
a 4-point response scale scored using a bimodal
method (symptom present “not at all” or “same
as usual = 0; “more than usual”  or “much more
than usual” = 1).
To determine whether there was a dose–
response relation, we categorized the results
from the GHQ-12 into three groups (0, 1–3 and 
4 points); a score of 4 or more denoted a case.15
This definition has been validated against stan-
dardized psychiatric interviews and has been
strongly associated with various psychological
disorders, such as depression and anxiety.17
Other covariables
Interviewers collected information on self-
reported smoking status (current, former or
never), alcohol consumption (units per week),
moderate to vigorous physical activity (fre-
quency per week), ethnicity (white, black, South
Asian and other) and socioeconomic status as
indexed by occupational social class (profes-
sional/intermediate, skilled non-manual, skilled
manual and part-skilled/unskilled). In addition,
interviewers measured participants’ height and
weight to calculate body mass index (BMI). Dur-
ing a separate visit, nurses collected data on his-
tory of clinician-diagnosed cardiovascular dis-
ease (stroke, angina or heart attack), diabetes and
the use of antihypertensive medications.
Determining cause of death
We classified underlying causes of death using
information collected from participants’ death
certificates together with any additional informa-
tion provided by the certifying physicians (e.g.,
secondary cause of death). We recorded diag-
noses for primary cause of death using the Inter-
national Classification of Diseases, ninth (ICD-
9) and tenth (ICD-10) revisions (ischemic heart
disease: ICD-9 codes 410–414, ICD-10 codes
I20-I25; cerebrovascular disease: ICD-9 codes
430–438, ICD-10 codes I60-I69).
Statistical analysis
We used χ2 tests and analyses of variance to
determine differences in baseline characteristics
across the three psychological distress groups.
We used Cox proportional hazards models to
compute hazard ratios (HRs) with accompanying
95% confidence intervals (CIs) for the associa-
tion between death from cardiovascular disease
and psychological distress. We used age as the
time scale, with entry delayed to age at cohort
inception; for participants with no record of an
event (i.e., those who did not die from cardiovas-
cular disease or from some other cause), the data
were censored at Feb. 28, 2008. We examined the
proportional hazards assumption by calculating
time-dependent interaction terms between GHQ-
12 score and the logarithm of the follow-up
period, which were all nonsignificant. With no
clear differences in our results between men and
women, we pooled the data and adjusted for sex,
age, ethnicity, socio economic status, smoking
status and use of antihypertensive medications.
The rationale for the inclusion of these covari-
ables was that they were both important predic-
tors of cardiovascular disease and associated with
psychological distress. We further adjusted for
survey year to address any concerns about time
lag effects. Given that there were considerable
amounts of missing data on alcohol consumption,
physical activity,  physician-diagnosed diabetes
and BMI, we performed additional sensitivity
analyses on a subsample in which these covari-
ables were added to the model.
Results
The initial study sample included 96 605 adults,
10 065 (10.4%) of whom did not consent to mor-
tality follow-up and were removed from the analy-
ses. Nonconsenting adults were older than those
who gave consent (64.3 v. 56.1 yr, p < 0.001).
Further exclusion criteria included  clinician-
diagnosed cardiovascular disease at baseline (n =
4160), and missing data on the exposure variable
(i.e., psychological distress, as measured by the
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GHQ-12) (n = 13 728). The final cohort comprised
68 652 adults (mean age 54.9 [standard deviation
13.9] yr, 45.0% male sex, 96.1% white ethnicity).
Participants who gave their consent but who were
excluded from the analysis were older (60.7 v.
54.7 yr) and more likely to be men (46.5% v.
44.6%) than those included in the final cohort.
Psychological distress was evident in 14.7% of
participants. People reporting psychological dis-
tress were younger and were more likely to be
women, come from lower/working classes, smoke
and use antihypertensive medications (Table 1)
than participants not reporting such distress.
Over an average of 8.1 years’ follow-up (max-
imum 14 yr), there were 2367 deaths due to car-
diovascular disease (1010 deaths from ischemic
heart disease, 562 deaths from cerebrovascular
disease, 795 other cardiovascular-related deaths).
Psychological distress was associated with death
from cardiovascular disease, and the relation
remained consistent for specific disease out-
comes, including ischemic heart disease and cere-
brovascular disease (Table 2). Other independent
risk factors for death due to cerebrovascular dis-
ease included age (per-year increase: HR = 1.16,
95% CI 1.15–1.17), smoking (multivariable
HR = 1.71, 95% CI 1.33–2.19) and use of anti -
hypertensive medications (multivariable HR =
1.26, 95% CI 1.04–1.52). The association be -
tween psychological distress and cerebrovascular
disease was only marginally attenuated after
adjusting for possible confounders (Table 2).
Sensitivity analysis
We wanted to examine the potential role of
blood pressure as a mechanism in explaining the
link between psychological distress and cere-
brovascular disease. Using data from the sub-
sample of participants for whom information on
blood pressure was available (n = 52 481, 432 of
whom died from cerebrovascular disease), we
found that the association between psychological
distress and cerebrovascular disease was similar
to that of the main cohort (age- and sex-adjusted
HR 1.64, 95% CI 1.27–2.12); however, adjusting
for systolic blood pressure did not attenuate the
effect estimate (HR 1.69, 95% CI 1.30–2.18).
We performed a second analysis using data
from the subsample of participants for whom
data on covariables including alcohol consump-
tion, physical activity, physician-diagnosed dia-
betes and BMI (n = 21 385) were available, but
additional adjustments for these variables only
marginally changed the results (Appendix 2,
available at www.cmaj.ca /lookup /suppl /doi :10
.1503 /cmaj .111719 /-/DC1.).
We performed a further sensitivity analysis in
which missing data were estimated using multi-
ple imputation methods. The missing values for
covariables were imputed using five imputations
based on maximum-likelihood estimates. We
saw minimal differences between the original
results and those found using the imputed
dataset. For example, for an increase of one stan-
dard deviation in GHQ-12 score, the risk of
death due to cerebrovascular disease was 1.09
(95% CI 1.04–1.15) using the original data and
1.12 (85% CI 1.08–1.17) using the imputed data. 
Our final sensitivity analysis involved remov-
ing all cardiovascular disease deaths in the first
two years (n = 411) after the inception of each
individual survey, which did not appreciably
change any of our results.
Interpretation
We saw an association between psychological dis-
tress and risk of cerebrovascular disease among
our participants, all of whom had been free from
cardiovascular disease at baseline. This associa-
tion was similar in size to the association between
psychological distress and ischemic heart disease
in the same group. Our results were largely
unchanged by controlling for a range of covari-
ables relevant to cardiovascular disease outcomes.
To date, most of the research in this area has
focused on coronary artery disease. Previous
studies have been limited by the rarity of cere-
brovascular events, a limited range of covariables,
the unknown influence of existing comorbidity
on psychological distress (reverse causality) and
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Table 1: Characteristics of the study participants at baseline (n = 68 652) 
 GHQ-12 score 
Characteristic 
0 
(n = 41 665) 
1–3 
(n = 16 915) 
≥ 4 
(n = 10 072) 
Age, yr, mean (SD) 55.1 (13.5) 55.1 (14.4) 53.8 (14.1) 
Male, % 47.9 42.5 37.5 
Socioeconomic group, %    
 Professional 40.3 38.8 34.1 
 Intermediate 40.8 40.7 40.9 
 Partly skilled/unskilled 18.9 20.5 25.0 
Smoking status, %    
 Never 42.4 40.9 39.1 
 Former 36.7 35.6 31.9 
 Current 21.0 23.5 29.0 
Use of antihypertensive 
agents, %* 10.9 12.5 12.1 
White ethnicity,  % 96.6 95.9 95.2 
Note: GHQ-12 = 12-item General Health Questionnaire. 
*Includes diuretics, angiotensin-converting enzyme inhibitors, β-blockers and calcium-channel 
blockers. 
few data from women. Our study adds substan-
tially to the extant literature, because it over-
comes some of these weaknesses by em ploying a
large, well-characterized cohort with a sufficient
number of cardiovascular disease events.
Our results are consistent with what literature
does exist.13,18 In the European Prospective Inves-
tigation into Cancer — Norfolk study, which
involved 20 627 participants who were stroke-
free at baseline, psychological distress as mea-
sured using the Mental Health Inventory was
associated with fatal and nonfatal stroke; depres-
sive symptoms did not show this association.13
Although the GHQ-12 includes items covering
symptoms of depression, it is generally viewed
as a measure of overall mental health; the GHQ-
12 also includes items covering symptoms of
anxiety, social dysfunction, sleep disturbance
and loss of confidence. Nevertheless, the effect
estimates for psychological distress and cere-
brovascular disease we saw are comparable with
those seen in a recent meta-analysis for depres-
sion and stroke (pooled adjusted HR 1.45,
95% CI 1.29–1.63).12 However, other aspects of
psy chological dysfunction may have importance.
For example, sleeping problems have previously
been associated with increased risk of death due
to cardiovascular disease,19 but the link with anx-
iety is less clear.20
Although the effect estimates of psychologi-
cal distress were similar for cerebrovascular and
ischemic heart disease, the mechanisms might
not necessarily be the same because of the differ-
ences in pathogenesis of atherosclerotic lesions
in coronary and cerebral arteries.21,22 Blood pres-
sure is a plausible mechanism linking psycho-
logical stress and risk of stroke. For example,
men with exaggerated systolic blood pressure
reactivity to stress had 72% greater risk of inci-
dent stroke over 11 years  follow-up.23 Neverthe-
less, using the same cohort as in the current
study, we recently showed that psychological
distress is associated with patients knowing that
they have hypertension, but not with elevated
blood pressure in participants without a diagno-
sis of hypertension.24
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Table 2: The association between psychological distress and death due to cardiovascular disease among 
the study participants (n = 68 652) 
Mental distress, score on GHQ-12 Cases, no. 
Age- and sex-
adjusted HR 
(95% CI) 
Multivariable 
adjusted* HR 
(95% CI) 
Cerebrovascular disease     
0    n = 41 665 
295 
1.00 1.00 
1 – 3    n = 16 915 
160 
1.21 (1.00–1.47) 1.20 (0.99–1.46) 
≥  4   n = 10 072 
107 
1.67 (1.34–2.09) 1.66 (1.32–2.08) 
p for trend  < 0.001  < 0.001 
Ischemic heart disease    
0    n = 41 665 
548 
1.00 1.00 
1– 3      n = 16 915 
288 
1.31 (1.13–1.51) 1.26 (1.09–1.46) 
≥  4   n = 10 072 
174 
1.65 (1.39–1.96) 1.59 (1.34–1.88) 
p for trend  < 0.001  < 0.001 
All cardiovascular disease     
0  n = 41 665 
1273 
1.00 1.00 
1– 3    n = 16 915 
652 
1.21 (1.09–1.32) 1.16 (1.06–1.28) 
≥  4   n = 10 072 
442 
1.68 (1.50–1.87) 1.61 (1.44–1.79) 
p for trend  < 0.001  < 0.001             
Note: CI = confidence interval, GHQ-12 = 12-item General Health Questionnaire, HR = hazard ratio.  
*Model adjusted for age, sex, ethnicity, socioeconomic group, smoking, use of antihypertensive medication and year in which 
the survey was done. 
In addition, adjustment for antihypertensive
medications as a proxy of increased blood pres-
sure had minimal effect on the association be -
tween distress and cerebrovascular disease in the
present analysis. Thus, a possible causal associa-
tion between distress and hypertension remains
doubtful. Other plausible mechanisms might
involve inflammatory pathways and dysregulated
function of the autonomic nervous system,
although existing data relating to psychological
distress and cardiovascular disease have been
equivocal.25,26 There has been a lack of research
into the mechanisms that might explain the asso-
ciation between psychological distress and stroke,
and further work is needed to address this need.
Limitations
We found that the size of the association
between psychological distress and death from
cardiovascular disease diminished as the dura-
tion of follow-up increased (Appendix 1), which
may suggest reverse causality. That is, undiag-
nosed somatic illness will be associated with
both an increased prevalence of psychological
distress and an increased risk of death. The im -
pact of hidden somatic illness will diminish as
the length of follow-up increases, because people
with such disorders die — potentially resulting
in the trend we saw in the current study. In addi-
tion, with greater time between measuring psy-
chological distress and death from cardiovascu-
lar disease, there is greater opportunity for other
risk factors to play a role in the association. An
additional explanation for the dilution of this
effect is changes in psychological distress during
follow-up resulting in the misclassification of
exposure; that is, as time passes, there is an
increasing opportunity for those who had psy-
chological distress at baseline to no longer have
distress, and vice versa.
We used a large cohort representative of the
general population to examine the associations
between psychological distress and cerebrovascu-
lar disease. However, because of the lack of
 follow-up data on psychological distress, we
were unable to account for the effects of changes
in distress over time. Furthermore, the GHQ-12 is
not designed to assess specific aspects of mental
health such as anxiety and depression, although it
has been specifically validated as a measure of
depression as assessed by the Composite Interna-
tional Diagnostic Interview.17 Measuring symp-
toms of anxiety, depression and dysfunction as a
unidimensional construct of psychological dis-
tress is particularly relevant in community-based
samples such as ours, because mental health
problems in the community are frequently char-
acterized by shifting patterns of symptoms that
resist precise clinical classification.27 We have
previously shown that psychological distress
(GHQ-12 score > 3) was associated with incident
cardiovascular events independent of the use of
antidepressant medications (HR 1.48, 95% CI
1.29–1.70).28 Thus, to some extent, the GHQ-12
might be independent of depression itself.
The participants excluded from our analyses
were older, and thus probably had a greater risk
of stroke and poorer mental health, which may
have introduced bias into our analysis. In addi-
tion, we cannot discount the possibility of re -
verse causation — underlying disease at baseline
might have increased psychological distress.
However, we excluded all respondants with a
clinical history of cardiovascular disease and
performed our analyses again after removing all
deaths that occurred in the first two years of
 follow-up; this additional analysis did not affect
our results.
Finally, different subcategories of cerebrovas-
cular disease could not be reliably separated
using the information from death certificates
(57.9% of all deaths due to cerebrovascular dis-
ease were unspecified). Further work is required
to determine whether psychological risk factors
have a uniform affect on different subcategories
of cerebrovascular disease.
Conclusion
Little is known about the psychological risk fac-
tors for cerebrovascular disease. In this large
cohort representative of the general population,
we saw an association between psychological
distress and risk of death from cerebrovascular
disease. Our data suggest that questionnaires
such as the GHQ-12 could be of value in system-
atic screening aimed at improving the recogni-
tion of common mental disorders for reducing
the risk of cardiovascular disease. Our results
have several implications for further research. In
particular, data from controlled trials that exam-
ine the effects of reducing distress on car dio -
vascular disease outcomes are needed to confirm
the results we have seen.
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